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ABSTRACT
Notch pathway activation plays a central role in the pathogenesis of
many glomerular diseases. We have previously shown that Notch4
expression was upregulated in various renal cells in human
immunodeficiency virus (HIV)-associated nephropathy (HIVAN)
patients and rodent models of HIVAN. In this study, we examined
whether the Notch pathway can be distinctly activated by HIV-1
gene products and whether Notch4, in particular, can influence
disease progression. Using luciferase reporter assays, we did not
observe activation of the NOTCH4 promoter with the HIV protein
Nef in podocytes. Further, we observed upregulated expression of a
gamma secretase complex protein, presenilin 1, but not Notch4, in
podocytes infected with an HIV-1 expression construct. To assess
the effects of Notch4 on HIVAN disease progression, we
engineered Tg26 mice with global deletion of the Notch4
intracellular domain (Notch4dl), which is required for signaling
function. These mice (Notch4d1/Tg26+) showed a significant
improvement in renal function and a significant decrease in
mortality compared to Tg26 mice. Histological examination of
kidneys showed that Notch4d1/Tg26+ mice had overall glomerular,
tubulointerstitial injury and a marked decrease in interstitial
inflammation. A significant decrease in the proliferating cells was
observed in the tubulointerstitial compartments of Notch4d1/Tg26+
mice. Consistent with the diminished inflammation, kidneys from
Notch4d1/Tg26+ mice also showed a significant decrease in
expression of the inflammatory cytokine transcripts Il-6 and Ccl2,
as well as the master inflammatory transcription factor NF-κB
(Nfkb1 transcripts and p65 protein). These data identify Notch4 as
an important mediator of tubulointerstitial injury and inflammation in
HIVAN and a potential therapeutic target.
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INTRODUCTION
Human immunodeficiency virus (HIV)-associated nephropathy
(HIVAN) is a complication of HIV infection characterized by
pathological changes in the kidney that include collapsing focal
segmental glomerulosclerosis, tubular injury and dilatation,
significant interstitial inflammation and tubuloreticular inclusions.
HIVAN disproportionally affects individuals of African descent,
largely due to high allele frequency of specific polymorphisms
(Freedman and Langefeld, 2012; Papeta et al., 2011). With the
advent of highly active anti-retroviral therapy (HAART), the
incidence of HIVAN has greatly declined (Razzak Chaudhary
et al., 2015). However, HIVAN remains a leading cause of end-stage
renal disease (ESRD) in patients with HIV-1 infection, and HIVAN
patients who reach ESRD experience excessive mortality compared
with other ESRD patients (Gonzales et al., 2010; Li and Zhuang,
2014; Rachakonda and Kimmel, 2010; Razzak Chaudhary et al.,
2015). Even in the HIV-infected patients who avoid HIVAN,
chronic use of HAART itself is associated with nephrotoxicity, drug
resistance and other serious complications. Thus, there is a need
for alternative or combined therapies that may combat HIV-
1-associated chronic kidney diseases and limit undesired effects.
Notch signaling is a developmental pathway that is required to
orchestrate proper cell fate decisions, during embryogenesis and
differentiation (Kopan and Ilagan, 2009; McCright et al., 2001), and
has been implicated in HIVAN pathogenesis (Sharma et al., 2010,
2013). In mammals, there are four Notch receptors (Notch1,
Notch2, Notch3, Notch4) and five ligands [ jagged 1 (Jag1), jagged
2 (Jag2), delta-like 1 (Dll1), delta-like 2 (Dll2) and delta-like 4
(Dll4)]. Canonical Notch signaling is activated when a Notch
ligand binds to its receptor, which initiates a series of proteolytic
events. The final proteolytic event is mediated by presenilin-
dependent gamma-secretase-like proteases, resulting in release of
the Notch intracellular domain (NICD) and its translocation into
the nucleus. In the nucleus, the NICD associates with a
transcription factor, RBP-jk (also known as Rbpj and CBF-1),
and activates the expression of members of the Notch effector
protein family, Hairy enhancer of split (Hes and Hey) (Kopan and
Ilagan, 2009).
Notch signaling is primarily known as a developmental pathway;
however, post-developmental Notch activation has been associated
with pathological conditions, including kidney disease (Arboleda-
Velasquez et al., 2008; Bielesz et al., 2010; El Machhour et al.,
2015; Sharma et al., 2011). Moreover, non-redundant roles of Notch
signaling have been described (Cheng et al., 2007; Djudjaj et al.,
2012). Notch1 signaling appears to play a major role in many
glomerular diseases (Murea et al., 2010; Waters et al., 2008). We
previously reported that Notch4 is highly upregulated in HIVAN in
both glomerular and tubular cells, and that Notch inhibition by
gamma secretase inhibitor (GSIXX, or dibenzazepine) can ameliorateReceived 22 May 2019; Accepted 6 November 2019
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the disease progression (Sharma et al., 2010, 2013). The specific role
ofNotch4 activation inHIVAN, andwhether the increased expression
is causative or a consequence of the disease, remains unanswered.
In the present study, we explored the role of Notch4 activation in
HIVAN. We found that HIV-1 increased the gamma secretase
activity but did not induce Notch4 activation in podocytes in
culture. Further, Notch4 deletion in mice transgenic for HIV-1
proteins (Tg26 mice) resulted in significant protection from
HIVAN, with a reduction in tubulointerstitial proliferation,
inflammation and injury, preservation of renal function and a
significant increase in survival.
RESULTS
Activation of the Notch signaling pathway by HIV-1
The Tg26 mouse is a widely studied model of HIVAN in which all
HIV-1 proteins except gag and pol are expressed (Dickie et al.,
1991; Kopp et al., 1992). The heterozygous Tg26 mice (Tg26+)
replicate HIVAN pathology, which is mainly due to the transgene
expression in the kidneys (Bruggeman et al., 1997). We have
previously shown that the Notch signaling pathway, specifically
Notch4, is activated in several cell types in the kidney, including
podocytes, parietal epithelial cells and renal tubular cells, in Tg26+
mice and HIVAN patients (Sharma et al., 2010, 2013). In addition,
we found that there are scattered Notch4-expressing cells in the
interstitium (Fig. 1A, arrows). To determine whether Notch4 is a
contributor to HIVAN pathogenesis in podocytes, we infected
differentiated immortal human podocytes with either virions
obtained from vector alone or an HIV-1 construct expressing
seven of the nine HIV-1 genes (pNL4-3:ΔG/P-GFP). Western blots
of lysates from these cells showed that the presence of HIV-1 genes
significantly increased the expression of a gamma secretase
complex component, presenilin 1 (PS-1; also known as Psen1),
indicating that Notch signaling is activated. However, the activated
signaling component of Notch4 [Notch4 intracellular (IC)] was not
significantly increased compared to the vector-infected controls
(Fig. 1B,C). These data indicate that HIV infection results in Notch
pathway activation but may not involve activation of Notch4 in
particular, in immortal differentiated podocytes in vitro.
The HIV-1 gene product Nef does not induce NOTCH4
promoter activity in podocytes in vitro
We next determined whether HIV-1 acts on Notch4 at the promoter
level. The NOTCH4 promoter at chromosome 6 has several cis
elements, including a unique activator protein (AP1) motif, in
proximity to the transcription start site. These unique sites are not
present in the promoter regions of the NOTCH1 receptor gene
(Fig. 2A) (Wu et al., 2005). Interestingly, the HIV-1 proteins Nef,
Tat, Vpr and Vpu activate and recruit AP1 in a variety of cells
(Kumar et al., 1998; Varin et al., 2005, 2003). The AP1 transcription
factor is a hetero- or homodimeric complex that contains members
of the Jun (c-Jun, Jun-B and Jun-D) and Fos (c-Fos, Fos B) protein
families. Stress-activated protein kinase/Jun N-terminal kinase
(SAPK/JNK) signal transduction phosphorylates and activates
Jun, which in turn activates AP1. To investigate the molecular
mechanisms involved in Notch4 activation in HIVAN, we first
verified that Tg26+ mouse kidneys overexpressed both c-Jun and
Fos B compared to the normal wild-type (WT) FVBmice (Fig. 2B).
These observations imply that HIV proteins upregulate Notch4
transcription and may require AP1 activation to achieve this.
To determine whether there is any NOTCH4 promoter activity in
the immortal podocytes in vitro, reporter luciferase assays were
performed. Podocytes were transfected with a GFP construct and
∼50% transfection efficiency was achieved, with most cells showing
moderate expression of GFP and some very high expression at 48 h
(Fig. 2C). Podocytes were then co-transfectedwith vector (Vec) alone
or a luciferase construct containing the NOTCH4 promoter that
contained the AP1 binding site in close proximity to the transcription
start site (Pro), or NOTCH4 construct with a mutated AP1 site from
TGACTCA to TGGCTAGAC (Mut) (Fig. 2A) (Wu et al., 2005),
along with plasmids expressing Nef or vector alone. As shown in
Fig. 2D, we did not achieve any significant NOTCH4 promoter
activity under any condition. This prompted us to verify our luciferase
assays in human embryonic kidney (HEK) 293T cells with the same
constructs. In HEK 293T cells, there was significant internal
NOTCH4 promoter activity and Nef further significantly enhanced
this activity (Fig. S1). NOTCH4 promoter activation was also seen in
the presence of a separate gene, Tat (Fig. S1). In these cells, loss of
AP1 binding did not diminish HIV-dependent activation of the
NOTCH4 promoter in the presence of either Nef or Tat (Fig. S1).
These data indicate that the NOTCH4 promoter is neither active nor
activated by Nef in podocytes in culture.
Notch4 deletion is not compensated by other Notch
receptors
Although podocytes in culture did not appear to activate NOTCH4
with HIV-1, this does not rule out the possibility of other glomerular
and tubular cells exhibiting this phenomenon. Therefore, we opted
for an in vivo approach, as opposed to a cell-based approach, to
determine whether global deletion of Notch4 IC in the Tg26 mouse
model would be functionally relevant. For this purpose, we bred
HIV-1 transgenic mice (Tg26) with mice in which Notch4 IC was
globally deleted (Notch4d1) (Krebs et al., 2000). Mice homozygous
for the Notch4d1 gene are viable and fertile and do not show any
significant histological abnormalities (Krebs et al., 2000). These
mice express extracellular Notch4 receptor but no Notch4 IC, which
is required for the activation of Notch4 signaling (James et al.,
2014). Breeding of Notch4d1 and Tg26+ mice resulted in mice with
Fig. 1. HIV-1 induces activation of the Notch pathway.
(A) Immunohistochemistry (IHC) was performed for the presence of Notch4 on
renal paraffin sections from 3-month-old wild-type (WT) or Tg26+ mice. Arrows
indicate interstitial cells positive for Notch4 expression in Tg26+ mice
compared to WT mice. The leftmost panel represents the no primary antibody
control. (B) Differentiated immortal human podocytes were infected with empty
vector (Vec) or HIV-1 construct followed by protein blots for the presence of
presenilin1 (PS-1) and Notch4 intracellular (IC). (C) Protein blots were
quantitated for PS-1 (n=3) and Notch4 IC (n=6) using β-actin (as a loading
control), to which the values were normalized. Unpaired Student’s t-test was
used, and data are represented as fold change (*P<0.05).
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several genotypes. For our studies, we used four groups of mice: (1)
normal Notch4 alleles and no Tg26+ transgene (WT control); (2)
homozygous Notch4d1 alleles with no Tg26+ transgene (Notch4
control group; Notch4d1); (3) normal Notch4 alleles and Tg26+
transgene (Tg26 control group; Tg26+); and (4) Notch4d1mice with
Tg26+ transgene (Notch4d1/Tg26+).
Notch4 IC deletion in the kidney was verified by
immunohistochemistry (IHC) using an antibody that recognizes the
truncated intracellular domain of mouse Notch4. As shown in
Fig. 3A, when we compared the renal sections of Tg26+, WT and
Notch4d1/Tg26+ (N4d1/Tg26+), Notch4 expression was increased in
Tg26+ compared to the WT sections as expected. In N4d1/Tg26+
sections, there was no specific staining observed (Fig. 3A, arrows).
Quantitative reverse transcription PCR (RT-PCR) further verified
reduction ofNotch4 expression in theNotch4d1/Tg26+mice (P<0.05)
compared with the Tg26+ mice (Fig. 3B). Next, we determined
whether expression of other Notch receptors might compensate for
the loss of Notch4 IC. However, expression of the Notch1, Notch2
and Notch3 receptors was not affected by Notch4 IC deletion
(Fig. 3C-E). A significant increase in Notch3 expression in Tg26
micewas expected because Notch3 was another receptor that we have
previously found to be elevated in Tg26 kidneys (Fig. 3E) (Sharma
et al., 2010). Thus, the Notch receptor expression data suggest that
any observed effects in mice are likely to be mediated specifically by
deletion of Notch4. In Notch4d1/Tg26+ mice, Hes1 expression levels
were reduced to normal levels, suggesting that Notch4 is primarily
responsible for Hes1 upregulation in Tg26+ mice (P<0.05) (Fig. 3F).
Notch4 deletion increases survival rate in Tg26+ mice
To determine the effect of Notch4 IC deletion in Tg26+ mice, all
four groups of mice were monitored for 6 months after birth. As
expected, WT and Notch4d1 mice had 100% survival at 6 months
(data not shown). Tg26+ mice had low survival: ∼40% of the mice
were alive at 2 months and∼15% of the mice were alive at 6 months
of age (Fig. 4A). Strikingly, Notch4 deletion significantly reduced
mortality and increased survival in the Tg26+ mice. Approximately
80% of the Notch4d1/Tg26+ mice were alive at 3 months and ∼65%
were alive at 6 months (Fig. 4A).
To determine whether increased survival is associated with
improved renal function, albumin-to-creatinine ratio, proteinuria
and blood urea nitrogen (BUN) levels were measured in all the
groups at 3 months. Only 15-20% of the Tg26+ mice survived up to
6 months; therefore, we restricted the analyses to 3-month-old mice.
The albumin-to-creatinine ratio was significantly elevated in the
24 h collected urine of the Tg26+ mice compared to WT and
Notch4d1 (N4d1) mice, and dropped to almost normal levels
(P<0.05) in Notch4d1/Tg26+ mice (Fig. 4B). Albumin levels were
further assessed in 2 µl urine via Coomassie Blue staining. As
shown (Fig. 4C), albumin was elevated in most Tg26+ mice [both
males (M) and females (F)] with some expected variability between
males and females. In Notch4d1/Tg26+ mice, albumin/proteinuria
was markedly reduced. As expected, Tg26 mice had diminished
renal function, as demonstrated by elevated serum BUN levels
(Fig. 4D). Notably, the Notch4d1/ Tg26+ mice had preserved renal
function, with BUN levels comparable to those ofWT andNotch4d1
Fig. 2. HIV-1 gene products do not activate the Notch4 promoter in podocytes in vitro. (A) Schematic showing promoter regions of Notch1 and Notch4.
The Notch4 promoter contains two AP1 sites, one in close vicinity to the transcription start site [−70 base pairs (bp)]. The sequences involved in the intact AP1
binding site (Pro) and the mutant AP1 binding site (Mut) on the Notch4 reporter construct are shown in the boxes below. (B) Renal tissue lysates from WT and
Tg26+ mice were used for protein blotting and probed for the presence of c-jun and fos B. Ponceau S was used to show loading. (C) Immortal differentiated
podocytes were transfected using GFP-expressing vector. The transfection efficiency of podocytes is shown by cells expressing GFP. Arrows show cells with
low and high GFPexpression after 48 h (right panel). The left panel shows cells in brightfield (BF). (D) Dual luciferase reporter assays showNotch4 transcriptional
activity in podocytes transfected with empty vector (Vec), Notch4 promoter reporter construct (Pro) or Notch4 promoter reporter construct with mutated
AP1 site (Mut), with empty vector (EV) or Nef expression constructs (Nef ). Reporter activity was normalized to renilla luciferase activity and expressed
as relative light units (n=3). One-way AVOVA did not reveal any significance.
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(N4d1) mice. These data indicated that Notch4 deletion slows the
decline in renal function in Tg26+ mice.
Increased survival in Notch4-deleted Tg26+ mice is
associated with overall decrease in interstitial injury,
glomerular injury and cell proliferation
To further determine factors influencing the longevity of Notch4d1/
Tg26+ mice, histological analysis was carried out. In both males and
females, there was an improvement in overall renal pathology in
Notch4d1/Tg26+ mice. A marked reduction in the percentage of
glomerular injury [from 55.05±18.6 to 16.05±5.3 (females) and
from 24.41±1.25 to 8.6±1.25 (P<0.05) (males)] was observed
(Fig. 5B). Very mild tubulointerstitial injury was observed, if any, in
the Notch4d1/Tg26+ male mice, and tubulointerstitial injury was
significantly reduced in Notch4d1/Tg26+ females compared to
Tg26+ controls. The Notch4d1/Tg26+ mice (Fig. 5A,C, right panels)
also had less interstitial inflammation compared to Tg26+ controls
(Fig. 5A,C, left panels). Overall proliferation was assessed by
Fig. 3. Verification of Notch4 IC deletion and expression of other notch receptors in kidneys ofN4d1/Tg26+mice. (A) IHC was performed in paraffin kidney
sections obtained from wild-type (WT), Tg26+, and Tg26+mice with Notch4 deletion (N4d1/Tg26+) for expression of Notch4. Arrows indicate glomerular
expression. (B-F) Quantitative RT-PCR was performed for Notch4, Notch1, Notch2, Notch3 and Hes1 expression in RNA isolated from renal tissues from WT,
Tg26+,N4d1 and N4d1/Tg26+mice. ΔΔCTmethod was used, and results were expressed as relative fold change (n=3 each). One-way ANOVAwas used and the
horizontal bars at the top of graphs show the significance (*P<0.05).
Fig. 4. Increased survival and protection of renal
function in N4d1/Tg26+ mice. (A) Tg26+ (n=37)
and N4d1/Tg26+ (N4d1/Tg26+) (n=14) mice were
monitored for 6 months for any lethality issues; results
are presented as percentage survival using Kaplan–
Meyer curve (P=0.0002). (B) Urine albumin-to-
creatinine ratio (µg/mg) was measured in all groups
in 24 h collected urine samples (*P<0.05).
(C) Proteinuria was also determined in 2 µl urine
loaded onto 10% SDS-polyacrylamide gel for
electrophoresis followed by staining with Coomassie
Blue. The arrowhead indicates the 2 µl bovine serum
albumin (BSA, 10 mg/ml) control band (M=males,
F=females). (D) Serum blood urea nitrogen (BUN)
levels were measured from all the groups and
analyzed using one-way ANOVA followed by Tukey’s
multiple comparison test. The results are presented as
mg/dl (*P<0.05).
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measuring proliferating cell nuclear antigen (PCNA), both in kidney
lysates by western blotting and in sections by IHC (Fig. 6A-C).
Intense PCNA-positive cells were seen in the tubulointerstitial
compartments in Tg26+ mice and were markedly reduced in
Notch4d1/Tg26+ sections. The quantitation of PCNA-positive cells
revealed that there was a reduction in PCNA-positive cells in the
tubulointerstitial compartment but not in glomeruli (Fig. 6B).
Western blotting for PCNA further showed an overall reduction in
PCNA levels (P<0.01) (Fig. 6C).
Notch4 deletion reduces inflammation in Tg26+ mice via
inactivation of inflammatory mediators, including NF-κB
To characterize the effects of Notch4 deletion on inflammation,
renal expression of the inflammatory cytokine monocyte
Fig. 5. Notch4 IC deletion rescues cortical tubulointerstitial and glomerular injury. (A,C) Kidney paraffin sections from Tg26+ and Notch4-deleted
Tg26 (N4d1/Tg26+) mice (n=5 each) were subjected to periodic acid–Schiff staining and blindly evaluated for glomerular and tubulointerstitial injury.
The arrowhead indicates sclerotic glomeruli. Note the hypercellularity in the Tg26+ mice sections. (B,D) Percentage glomerular or tubulointerstitial injury
was measured per kidney (n=5) for each group of mice. Statistical values were obtained using unpaired Student’s t-test (*P<0.05, **P<0.01).
Fig. 6. Notch4 IC deletion is associated
with decreased proliferating cells in the
tubulointerstitial compartments. (A) IHC was
carried out for the presence of proliferative nuclear
antigen (PCNA) in kidney sections from Tg26+
and N4d1/Tg26+ mice. (B) The total number of
interstitial cells stained positive for PCNA was
counted per field in about six random fields per
group. Each group consisted of three male mice
(n=3). The results are presented as number of
PCNA-positive cells/surface area (left). The
average number of PCNA-positive cells per
glomerulus in about six random fields per group
was also counted and averaged (n=3). The results
are presented as average number of positive cells/
glomerulus (right). (C) PCNA expression was
determined via immunoblotting, using Ponceau S
as a loading control, followed by semi-quantitative
analysis of bands (lower panel) using ImageJ.
Results are expressed as relative expression.
Statistical values were obtained using unpaired
Student’s t-test (**P<0.01).
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chemoattractant protein-1 (MCP-1) transcript Ccl2 and Il-6 were
measured by quantitative RT-PCR (Fig. 7A,B). MCP-1 is a
chemoattractant involved in macrophage recruitment in renal
injury and is known to be upregulated in human HIVAN (Kimmel
et al., 2003). IL-6 is an inflammatory cytokine that may
promote HIV gene expression in the kidney (O’Donnell et al.,
1998). Ccl2 mRNA levels were very low in the WT and Notch4d1
mice. In Tg26+, renal expression of Ccl2 was upregulated
approximately 6-fold (Fig. 7A) (P<0.01). Notch4 deletion restored
Ccl2 expression to WT levels. A similar pattern was observed with
Il-6 (Fig. 7B).
NF-κB is a pro-inflammatory master transcription factor that is
known to interact with HIV-1 long terminal repeat (LTR) and thus
possibly contribute to HIVAN pathogenesis. NF-κB is a
heterodimeric protein complex that consists of several different
NF-κB family proteins (Bruggeman et al., 2001; Martinka and
Bruggeman, 2006; Ross et al., 2005). We determined mRNA levels
of p50 subunit (Nfkb1) and protein localization of NF-κB (p65) in
the renal tissues of mice. Like the pattern described above for Ccl2
and Il-6, there was significant increase in mRNA expression of
Nfkb1 in Tg26+ mice, which dropped to normal levels in the
Notch4d1/Tg26+ mice (Fig. 7C) (P<0.05). Also, NF-κB protein
levels were elevated in the glomerular and interstitial/infiltrating
cells in Tg26+ mice, and expression was markedly reduced in
Notch4d1/Tg26+ mice (Fig. 7D).
DISCUSSION
Notch signaling has been relevant in several glomerular diseases,
but, of the four Notch receptors, Notch4 has been the least
investigated in this context. This is the first study to report a
functional role for Notch4 activation specifically in HIVAN.
Notch4 expression is generally restricted to the vasculature during
development. However, in previous studies, we observed that
Notch4 is upregulated in glomeruli and tubules in both Tg26+ mice
and human HIVAN (Sharma et al., 2010, 2013). For the current
study, we used Tg26 mice with a Notch4-targeted deletion of exons
21 and 22, Notch4d1 (Krebs et al., 2000). Notably, there was no
change in expression of the other Notch receptors in the kidneys of
these mice. Mice homozygous for this Notchd1 allele are viable and
fertile with slightly elevated blood pressure; the allele was later
found not to be a true null, as a truncated transcript encoding most of
the Notch4 extracellular domain was found to be expressed in these
mice (James et al., 2014). However, the mice lack the intracellular
domain of Notch4, which is required for signaling. Thus, the
ameliorative effects of Notch4d1 in the Tg26+mice reported here are
most likely due to the absence of Notch4 signaling, which implies
that Notch4 signaling facilitates HIVAN progression.
This study also investigated the nature of the link between HIV-1
and Notch4. In HEK 293T cells, Nef appeared to activate the
NOTCH4 promoter but activation was not dependent on the AP1
binding site. In cultured immortal podocytes, therewas noNOTCH4
promotor activity, and Nef did not appear to activate the NOTCH4
promoter further and AP1 mutation did not alter this activity. The
data suggested that Notch4 activation is not a major podocyte event
in HIVAN. However, we cannot rule out the possibility of this event
in other glomerular cells such as parietal epithelial cells or tubular
cells, in which Notch4 was found to be activated in HIVAN.
The available literature suggests other modes of interaction of
HIV-1 with the Notch pathway. One study employed a yeast two-
hybrid system to demonstrate that Tat protein interacted with EGF-
like repeats of Notch receptors (Shoham et al., 2003). However, in
vivo evidence of these interactions is still lacking. Another study
suggested an interaction of RBP-jk with the HIV-1 LTR promoter
on two RBP-jk binding sites, showing RBP-jk to be a repressor of
HIV-1 LTR, which was proposed to foster HIV latency (Tyagi and
Karn, 2007). Since the Notch IC domain that is released upon Notch
activation is known to convert RBP-jk from a repressor to a
transcriptional activator, it is possible that Notch activation
stimulates the HIV-LTR promoter and, hence, promotes entry into
the lytic cycle. Thus, it is exciting to speculate that a positive
Fig. 7. Notch4 IC deletion results in a significant loss of inflammatory markers including NF-κB. (A-C) RNA prepared from kidneys of WT, N4d1,
Tg26+ and N4d1/Tg26+ mice (n=3 each) were subjected to quantitative RT-PCR analysis using primers for Ccl2, Il-6 and Nfkb1. The results are expressed
as relative fold change (n=3) (D) IHC for NF-κB (p65) was carried out; arrows show NF-κB-positive cells in the interstitial as well as in the glomerular
compartments from Tg26+ mice. Statistical significance was obtained using one-way ANOVA, followed by Tukey’s multiple comparison test
(*P<0.05, **P<0.01).
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feedback loop may exist whereby Notch and HIV-1 interact and
mutually activate one another.
The Tg26mouse model was generated by transgene expression of
non-infectious HIV-1 DNA construct lacking the gag and pol
genes. The homozygous mice are runted at birth and die within
40 days after birth. Heterozygous mice (Tg26+) are normal at birth
but develop severe edema between 60 and 250 days of age and show
characteristics of nephrotic syndrome. Tg26+ mice develop ESRD
within 100 days, with high levels of proteinuria. Kidneys show
characteristic pathological changes, including focal segmental
glomerulosclerosis, minor mesangial hyper cellularity, significant
enlargement and vacuolization of glomerular parietal and visceral
epithelial cells, microcystic tubular dilatations, protein casts,
monocytic interstitial inflammation and interstitial fibrosis (Kopp
et al., 1992). The improvements in mortality and renal function in
the Notch4d1/Tg26+ compared to Tg26+mice were accompanied by
dramatic improvements in the pathological changes in the kidneys.
There was significant improvement in glomerular and
tubulointerstitial injury, and there was a dramatic decrease in
overall inflammation. Relevant to this, kidneys from the Notch4d1/
Tg26+ mice showed a significant decrease in expression of the
inflammatory cytokines Il-6 and Ccl2, as well as the inflammatory
transcription factor Nfkb1. These findings imply that Notch4
activation is one of the major determinants of increased
inflammation in HIVAN. The overall improved proteinuria and
glomerular lesions may be a secondary effect of improved
tubulointerstitial inflammation and injury in these mice. Our
study is supported by several other studies in which Notch
silencing inhibited the NF-κB pathway in prostate cancer cells,
pancreatic cancer cells and endothelial cells under inflammatory
condition (Quillard et al., 2010; Wang et al., 2009; Zhang et al.,
2017).
In our previously published expression data, Notch4 levels were
found to be increased in podocytes, parietal epithelial cells and
tubular cells (Sharma et al., 2013). Here, we find that the interstitial
cells also express Notch4 in the nucleus, although the identity of
these cells was not determined. Since many cells appeared to
activate Notch4 upon HIV-1 infection, a global knockdown of
Notch4 in the Tg26 mice was the approach taken in this study.
However, to pinpoint the cell type responsible for the disease
progression, conditional mouse models for cell specific deletion of
Notch may be required. Also, single-cell sequencing may be
illuminating. In the present study, we conclude that Notch4 deletion
can significantly decrease inflammatory responses in HIVAN, in
part by decreasing the tubulointerstitial injury mediated by NF-κB-
dependent inflammation. Thus, blocking Notch4 activation in
HIVAN may constitute a potential therapeutic approach.
MATERIALS AND METHODS
Animal care and protocol
Tg26+ and Notch4d1mice (The Jackson Laboratory) used in this study were
raised in accordancewith the guidelines of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All the mice used
were housed in micro-isolator cages, under aseptic and pathogen-free
conditions, on a high-efficiency particulate air-filtered, ventilated rack. The
protocols used in research were approved by the Institutional Animal Care
and Use Committee of the University of Kansas Medical Center (Kansas
City, KS, USA). Tg26+ and Notch4d1 were bred to obtain WT, Notch4d1,
Notch4d1/Tg26+ and Tg26+mice. As the Tg26+mice phenotype is restricted
to FVB background, we first backcrossed Notch4d1 (B6;129S1) mice onto
FVB background for at least eight generations to obtain Notch4d1 mice on
FVB background. Mice were euthanized at 3 months for disease evaluation.
Before euthanasia, 24 h urine was collected for evaluation of proteinuria and
albumin-to-creatinine ratio. Blood was collected for serum isolation at the
time of euthanasia. One half of a kidney from each mouse was fixed in 4%
paraformaldehyde overnight, followed by a change in 70% ethanol. The
second half and the second kidney were snap frozen for RNA isolation and
protein lysates and stored at −80°C. A batch of mice was monitored for life
expectancy for 6 months.
Antibodies and reagents
The following antibodies were used: anti-presenilin 1 (1:1000, GenScript,
A00881-40), anti-β-actin (1:1000, Sigma-Aldrich, A2228). anti-PCNA
(1:100, Santa Cruz Biotechnology, sc-56) (c-Jun and Fos B, 1:500 each,
Santa Cruz Biotechnology, 74543 and 8013), anti-NF-κB (p65) (1:100,
Cell Signaling Technology, 8242) and anti-Notch4 (1:1000 for western
blotting, 1:100 for IHC, Lifespan Biosciences, C9117).
Renal function evaluation
Quantification of BUN in serum was performed using a Quantichrom Urea
Assay Kit (Bioassay Systems), according to the manufacturer’s protocol.
Urinary albumin and creatinine were assayed using a mouse albumin ELISA
kit (Bethyl Laboratories) and urinary creatinine assay kit (Cell Biolabs).
Results were expressed as albumin-to-creatinine ratio. To get rid of any
floating cells in urine, the urine was centrifuged and then 2 µl was loaded
onto 10% SDS-polyacrylamide gel for electrophoresis followed by
Coomassie Blue staining. Bovine serum albumin (BSA) (2 µl; 10 mg/ml)
was used as a positive control.
Histology
Kidneys were fixed in 4% paraformaldehyde overnight followed by 70%
ethanol. The tissues were processed and embedded in paraffin at the core
facilities of the University of Kansas Medical Center. Five-micrometer
sections were stained by periodic acid–Schiff (PAS) and Hematoxylin and
Eosin methods. Slides were examined in a blinded fashion by a renal
pathologist (T.A.F.) and scored for tubulointerstitial disease and glomerular
injury (n=5 each group). The percentage area with tubulointerstitial disease
(enlarged, reactive tubular nuclei, tubular casts, tubular dilatation and
interstitial fibrosis) was estimated by inspection for each section. For
glomerular injury score, the number of glomeruli with disease (segmental and
global sclerosis, adhesion to Bowman’s capsule) was counted per section.
Cell culture
All cell lines used were verified and were free of mycoplasma
contamination. HEK 293T cell lines were maintained in Dulbecco’s
modified eagle medium/F-12 supplemented with 10% fetal bovine serum
(FBS) and penicillin (100 U/ml)/streptomycin (130 µg/ml) (Pen/Strep)
(Gibco by Life Technologies). Human immortal podocytes, a kind gift from
Dr Moin Saleem (Saleem et al., 2002), were maintained at 33°C in a growth
medium containing RPMI 1640 (Hyclone) [supplemented with 10% FBS,
1× Pen/Strep, 1× insulin-transferrin-selenium (GenDEPOT)] to promote
expression of the SV40T antigen in the presence of 5% CO2 permissive
conditions. To differentiate, 50% confluent cells were moved to 37°C (in 5%
CO2) to inactivate SV40T antigen and allowed to differentiate for 7-10 days.
For Notch expression studies, replication-defective viral supernatants
were prepared as described previously (Chandel et al., 2015; Husain et al.,
2002). Briefly, green fluorescence protein (GFP) reporter gene (pEGFP-C1,
from Clontech) was substituted in place of gag/pol genes in HIV-1 proviral
construct pNL4-3, resulting in a pNL4-3:ΔG/P-GFP construct. This
construct was used to produce high-titer virus stocks. The HIV-1 gag/pol
and VSV.G envelope genes were used in trans using pCMV R8.91 and
pMD.G plasmids, respectively, and were provided by Dr Didier Trono (Salk
Institute, La Jolla, CA, USA) as kind gifts. As a negative control, pHR-
CMV-IRES2-GFP-ΔB construct containing HIV-1 LTR and GFP empty
expression vector was used. For production of infectious viral supernatants,
HEK 293T cells were transiently transfected using an effectene kit (Qiagen),
according to the manufacturer’s instructions. After 48 h, when almost all
(∼90%) cells appeared positive for GFP (∼72 h), the medium was collected
and filtered with 0.45-μm syringe filters. For infections, 1.5 μl polybrene
(EMD, Millipore) was added per 3 ml of virus medium (8-10 µg/ml) and
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added dropwise to the differentiated podocytes growing on 10 cm2 plates.
Normal culture medium (7 ml) was added after 4 h and cells were used after
72 h, when 60-70% of the podocytes appeared GFP positive.
Luciferase assays
Podocytes were seeded into 24-well plates and allowed to reach 50%
confluency at 33°C, after which they were moved to 37°C to differentiate for
7 days. Co-transfections using pcDNA3.1SF2-Nef or empty vector [kind gifts
from Dr Ashok Chauhan (Mehla et al., 2010; Zhang et al., 2010)] were
performed, along with NOTCH4 promoter reporter construct with or without
intact AP1 binding sites. The NOTCH4 promoter reporter construct was
kindly provided by Dr Emery Bresnick (University of Wisconsin–Madison,
Madison, WI, USA). Transfections were performed using Lipofectamine
RNAiMAX Reagent (Invitrogen), according to the recommended procedure.
Renilla vector construct pGl4.70 (hRluc) was used in each transfection to
control for internal luminescence (Promega). After 48 hours of incubation,
firefly and renilla luciferase activities were detected with a dual-luciferase
reporter assay (Promega), according to the manufacturer’s protocol.
Quantitative RT-PCR
Total RNAwas isolated from tissues using Trizol (Life Technologies), using
the manufacturer’s protocol. RNA concentration and purity were
determined by nanodrop analysis. Complementary DNA (cDNA) was
prepared from 2 μg total RNA using a High-Capacity Reverse Transcription
Kit (Thermo Fisher Scientific). Quantitative RT-PCR was performed using
Power SYBR Green Master Mix (Applied Biosystems). Results were
normalized to 18S ribosomal RNA (rRNA) expression and calculated by the
comparative ΔΔCT. Briefly, Ct values for the housekeeping gene (Rn18s), as
well as for the gene of interest, were obtained for all samples (WT control,
Notch4d1, Tg26+ and Notch4d1/Tg26+). Delta Ct (ΔCt) values for the
samples were then calculated by subtracting the respective housekeeping
gene value from the Ct value of the samples. Delta Ct values of the WT
controls (n=3) were then averaged to obtain an average ΔCt value. The
average ΔCt value of the WT controls was then subtracted from the ΔCt
values of all the samples including WT controls to obtain the ΔΔCt value.
Relative fold gene expression was then calculated using the 2−ΔΔCT formula
for each control or test sample. Values from each group were averaged and
presented as relative fold gene expression as previously shown
(Chakravarthi et al., 2018). The primers used for quantitative analysis of
the various genes are listed in Table 1.
Cell lysates and western blots
Podocytes after infections were lysed for western blotting. Cells were
washed three times with ice-cold PBS and lysed with RIPA buffer [137 mM
NaCl, 50 mM Tris HCl pH 7.5, 12 mM EDTA, 1% IGEPAL and complete
protease inhibitor (Thermo Fisher Scientific)]. Kidney tissues (fresh or
frozen) were severed into small pieces and lysed in RIPA buffer with
protease inhibitors using 50-80 strokes with a dounce homogenizer as
shown previously (Idowu et al., 2018). Quantification of protein for cell or
tissue lysates was performed with BCA protein assay (Bio-Rad,
Hercules, CA, USA). Freshly prepared whole-cell extracts (50-100 μg)
were solubilized in 4× NuPage (Novex) sample buffer [containing 25%
tris(2-carboxyethyl) phosphine (TCEP)]. Samples were heated to 65°C for
10 min and then electrophoresed on 10% SDS-polyacrylamide gels, which
were subsequently transferred to polyvinylidene difluoride (PVDF)
membranes. Blocking of immunoblots was performed in 5% non-fat dry
milk, in PBST (PBS containing 0.1% Tween 20), for 1 h, at room temperature
(Betha et al., 2007). Blots were then washed with PBS, followed by overnight
incubation with appropriate dilutions of primary antibodies. Blots were washed
three times with PBST, at room temperature, and incubated with secondary
antibodies (Vector Laboratories) (1:5000 dilution in blocking solution), at room
temperature, for 1 h. The bound secondary antibody was detected by
chemiluminescence (Western Lightning Plus ECL, Perkin Elmer).
IHC
IHC was performed as described previously (Sharma et al., 2013). Kidney
sections from WT, Tg26+, Notch4d1 and Notch4d1/Tg26+ mice were
deparaffinized with xylene and hydrated with different grades of ethanol.
Further, these sections were treated and boiled in citrate buffer (10 mM
sodium citrate, 0.05% Tween 20, pH 6.0) and cooled to room temperature.
Sections were incubated for 30 min with 3% hydrogen peroxide to block
endogenous peroxidase activity, washed in PBS and blocked with 10%
normal serum (from the species the secondary antibody was raised in, in
PBS) for 1 h, followed by incubation for 1 h with primary antibodies in a
humidified chamber. After washing slides three times with PBS, they were
incubated for 1 h in 1:400 diluted biotin-conjugated secondary antibodies
(Vector Laboratories) for IHC and fluorescein/Texas Red-conjugated
antibodies for immunofluorescence (IF). Slides were washed four times in
PBS for 5 min each. For IF, the slides were mounted using Vectashield
(Vector Labs). For IHC analysis, the slides were further incubated with
avidin-biotin-peroxidase complex (ABC Elite, Vector Laboratories), which
was detected with diaminobenzidine (DAB, Sigma-Aldrich). Tissue
sections were then dehydrated with graded ethanols and mounted with
permount (Fisher Scientific, Pittsburg, PA, USA). Slides were viewed on a
Nikon Eclipse 80i upright microscope.
Statistics
Data are expressed as mean±s.e. Statistical significance was measured by
unpaired Student’s t-test for comparison between control and test groups. One-
way ANOVA was performed to compare more than two groups, followed by
Tukey’s multiple comparison test. P<0.05 was considered significant.
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